In this modern environment, the ABCA1, APOE (ε2 and ε4) and LCT polymorphisms have been associated with obesity, dyslipidemias, type 2 diabetes and other metabolic alterations [24,48,49,50,51,52,53]. This evidence concerns the gene ABCA1 and metabolic syndrome.